Ann: Change of Director's Interest Notice x5, page-16

Not really Booey, the stock owes me nothing as i was lucky enough to pickup and trade a lot more than i was entitled to from previous 2 CRs.

Totally different company now. Chair that has an impeccable track record, a formidable management team, and they're in a niche oncology sector that could bring large & swift rewards, particularly if a major starts taking a liking.

Additionaly we have some major investors that have joined the registery who are no mugs at this end of the market.

I dont have much invested in the market now days, but i have bought back into this one over the last few weeks.

Company MC still at a level that can move fast in multiples.